# Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe HS Within the Italian Population

> **NCT07543419** · — · RECRUITING · sponsor: **Novartis Pharmaceuticals** · enrollment: 250 (estimated)

## Conditions studied

- Hidradenitis Suppurativa

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07543419
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-17
- **Primary completion:** 2028-09-30
- **Final completion:** 2028-09-30
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2026-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07543419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07543419, "Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe HS Within the Italian Population". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07543419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*